Title: Compounds for Targeting Hepatocytes In Vivo. Number: 20040029826. Filed: Aug. 4, 2003. Lead Inventor: Alexander Sokoloff, Mirus.
The patent application, its abstract states, covers “compounds that bind to and are internalized by hepatocytes. Association of these compounds to other molecules or complexes can be used to target the molecules or complexes to hepatocytes in vivo or in vitro,” it adds.